MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 30.03.2023
HTG Molecular Diagnostics Operativer Cashflow 2011-2026 | HTGM
Operativer Cashflow Jährlich HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.4 M | -16.5 M | -16.3 M | -16.7 M | -13.2 M | -16.6 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -13.2 M | -18.4 M | -16.3 M |
Operativer Cashflow Vierteljährlich HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -16.4 M | -11.8 M | -5.94 M | - | -13.1 M | -8.9 M | -4.35 M | - | -12.7 M | -8.38 M | -3.93 M | - | -12.8 M | -8.77 M | -5.59 M | - | -10.6 M | -7.01 M | -2.7 M | - | -13.7 M | -9.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.7 M | -16.4 M | -9.2 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 98.33 | 0.9 % | $ 8.11 B |  Irlanda |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 13.71 | -0.22 % | $ 99.4 M |  Israel |
 |
Charles River Laboratories International
CRL
|
738 M | $ 155.46 | 1.83 % | $ 7.71 B | USA |
 |
Bioventus
BVS
|
74.7 M | $ 8.62 | 0.23 % | $ 574 M | USA |
 |
DexCom
DXCM
|
1.44 B | $ 64.24 | -1.56 % | $ 25.1 B | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 25.56 | 0.95 % | $ 710 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 17.01 | 3.4 % | $ 906 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | $ 103.57 | 0.29 % | $ 19.5 B | USA |
 |
Guardant Health
GH
|
-185 M | $ 85.49 | 1.75 % | $ 10.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 14.77 | 0.61 % | $ 447 M | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 17.88 | -6.63 % | $ 2.32 B | USA |
 |
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.83 | -1.05 % | $ 91.8 K | USA |
 |
Danaher Corporation
DHR
|
6.42 B | $ 187.32 | 0.57 % | $ 134 B | USA |
 |
IQVIA Holdings
IQV
|
2.65 B | $ 164.72 | 1.1 % | $ 28.3 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Illumina
ILMN
|
837 M | $ 118.94 | 2.92 % | $ 18.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 199.7 | -0.46 % | $ 22.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
1.48 B | $ 111.51 | -0.06 % | $ 33.9 B | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.11 | -0.89 % | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 9.0 | -0.99 % | $ 255 M | Israel |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.09 | -2.78 % | $ 1.97 B | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 16.52 | 0.12 % | $ 370 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.33 | 4.72 % | $ 399 M | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | - | - | $ 79.8 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 450.41 | 1.48 % | $ 13 B | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 114.22 | 3.11 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 173.74 | 0.49 % | $ 24.2 B |  Schweiz |
 |
Personalis
PSNL
|
-45.2 M | $ 6.72 | 1.97 % | $ 398 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 7.88 | -1.25 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-432 M | $ 187.85 | -1.29 % | $ 18.5 B | USA |
 |
Sotera Health Company
SHC
|
287 M | $ 13.42 | 0.71 % | $ 3.81 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
OPKO Health
OPK
|
-183 M | $ 1.19 | 2.59 % | $ 826 M | USA |